Cargando…
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta
Background: Multiple sclerosis (MS) patients permanently confronted with serious challenges from treatment regimen. Developing a new questionnaire in MS management, through evaluation of patients’ perspectives and knowledge regarding treatment will help to identify the sources of tension, and to bui...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Neurological Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240934/ https://www.ncbi.nlm.nih.gov/pubmed/25422736 |
_version_ | 1782345801943482368 |
---|---|
author | Abolfazli, Roya Elyasi, Azam Javadi, Mohammad Reza Gholami, Kheirollah Torkamandi, Hassan Amir-Shahkarami, Mohammad Etemadifar, Masoud Nasr, Zahra |
author_facet | Abolfazli, Roya Elyasi, Azam Javadi, Mohammad Reza Gholami, Kheirollah Torkamandi, Hassan Amir-Shahkarami, Mohammad Etemadifar, Masoud Nasr, Zahra |
author_sort | Abolfazli, Roya |
collection | PubMed |
description | Background: Multiple sclerosis (MS) patients permanently confronted with serious challenges from treatment regimen. Developing a new questionnaire in MS management, through evaluation of patients’ perspectives and knowledge regarding treatment will help to identify the sources of tension, and to build a therapeutic alliance. We purposed to describe MS patients’ understanding of their treatments. Methods: About 425 completed and returned questionnaire were assessed of a total of 500 recruited MS patients. The knowledge of correct using interferon-beta (IFN-β) and attitude toward medical care were assessed using self-reported questionnaires consisted of 25 items with validity of multidisciplinary panel and pre-testing on 20 patients. Results: Knowledge about IFN-β therapy was very low; however, attitude was at a high level. Female patients, self-injection ability, higher educational level, normal functional status, delay from the start of diagnostic workup to definite diagnosis, and being younger were related to a higher level of knowledge. Attitude was associated with functional status, family history of disease and the summary of knowledge variable. Conclusion: Developing educational interventions are needed for MS patients regarding to their low levels of knowledge. |
format | Online Article Text |
id | pubmed-4240934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Iranian Neurological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-42409342014-11-24 Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta Abolfazli, Roya Elyasi, Azam Javadi, Mohammad Reza Gholami, Kheirollah Torkamandi, Hassan Amir-Shahkarami, Mohammad Etemadifar, Masoud Nasr, Zahra Iran J Neurol Original Article Background: Multiple sclerosis (MS) patients permanently confronted with serious challenges from treatment regimen. Developing a new questionnaire in MS management, through evaluation of patients’ perspectives and knowledge regarding treatment will help to identify the sources of tension, and to build a therapeutic alliance. We purposed to describe MS patients’ understanding of their treatments. Methods: About 425 completed and returned questionnaire were assessed of a total of 500 recruited MS patients. The knowledge of correct using interferon-beta (IFN-β) and attitude toward medical care were assessed using self-reported questionnaires consisted of 25 items with validity of multidisciplinary panel and pre-testing on 20 patients. Results: Knowledge about IFN-β therapy was very low; however, attitude was at a high level. Female patients, self-injection ability, higher educational level, normal functional status, delay from the start of diagnostic workup to definite diagnosis, and being younger were related to a higher level of knowledge. Attitude was associated with functional status, family history of disease and the summary of knowledge variable. Conclusion: Developing educational interventions are needed for MS patients regarding to their low levels of knowledge. Iranian Neurological Association 2014-07-04 /pmc/articles/PMC4240934/ /pubmed/25422736 Text en Copyright © 2014 Iranian Neurological Association, and Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Abolfazli, Roya Elyasi, Azam Javadi, Mohammad Reza Gholami, Kheirollah Torkamandi, Hassan Amir-Shahkarami, Mohammad Etemadifar, Masoud Nasr, Zahra Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title | Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title_full | Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title_fullStr | Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title_full_unstemmed | Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title_short | Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta |
title_sort | knowledge and attitude assessment of iranian multiple sclerosis patients receiving interferon beta |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240934/ https://www.ncbi.nlm.nih.gov/pubmed/25422736 |
work_keys_str_mv | AT abolfazliroya knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT elyasiazam knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT javadimohammadreza knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT gholamikheirollah knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT torkamandihassan knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT amirshahkaramimohammad knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT etemadifarmasoud knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta AT nasrzahra knowledgeandattitudeassessmentofiranianmultiplesclerosispatientsreceivinginterferonbeta |